Sugary beverages may raise your risk of liver cancer
If you regularly drink soda or other sugary beverages, a new study may give you a reason to cut back.
Jun 10, 2026
0
9
Neoplasms: News and Research on Adenocarcinoma
MeSH tree: C04.557.470.200.025
Experimental drug combination shows early effectiveness in advanced kidney cancer
An experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a first-in-human clinical trial led by Mayo Clinic researchers.
Jun 5, 2026
0
3
New breakthrough in developing more personalized treatments for lung cancer
A study by the University of Barcelona has discovered why the two main types of lung cancer—adenocarcinoma of the lung and squamous cell carcinoma—respond differently to anti-angiogenic therapy, that is, drugs that block ...
Jun 3, 2026
0
8
Engineered Salmonella deliver cancer-killing viruses, shrinking liver and pancreatic tumors in mice
Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors—two cancers with an extremely ...
Jun 3, 2026
0
9
Shrunken genomes may drive rapid cancer evolution and poor outcomes
Researchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor patient outcomes, is far more widespread than previously thought. Comparing chromosome patterns ...
Jun 2, 2026
0
5
Next-generation PET tracer enables rapid, high-precision detection of kidney cancer
A new PET tracer targeting carbonic anhydrase IX (CAIX) has demonstrated exceptional sensitivity and high tumor-to-background contrast in detecting clear cell renal cell carcinoma (ccRCC), according to early clinical research. ...
Jun 1, 2026
0
4
Obesity may influence how breast cancer spreads
Obesity may change how early-stage breast cancer becomes invasive, according to a study by University of Oklahoma researchers published in The American Journal of Pathology.
May 28, 2026
0
3
Lung cancer cells can revert identity to a branching state, fueling resistance and aggressive growth
Oncologists have discovered that lung cancer cells can change their identity to resist treatment. Research published in Molecular Oncology reveals how lung cancer cells can become more aggressive and harder to treat by reactivating ...
May 27, 2026
0
4
Residual risks of liver cancer persist after hepatitis C cure, finds study
National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that patients with hepatitis C remain at a significantly elevated risk of hepatocellular carcinoma (HCC) ...
May 26, 2026
0
4
Clinical trial tests virus-immunotherapy combination for neuroendocrine tumors
A Phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment. Researchers at Sylvester Comprehensive ...
May 21, 2026
0
4
